MedPath

Ethanol

Generic Name
Ethanol
Brand Names
Dalmacol, Gattex, Healing Waters Aloe Cucumber Hand Sanitizer, Healing Waters Cotton Blossom Hand Sanitizer, Healing Waters Lemon Verbena Hand Sanitizer, Healing Waters Peach Nectarine Hand Sanitizer, Lupaneta Pack 1-month, Viva-drops Lubricating Eye Drops
Drug Type
Small Molecule
Chemical Formula
C2H6O
CAS Number
64-17-5
Unique Ingredient Identifier
3K9958V90M
Background

A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in alcoholic beverages.

Indication

For therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated.

Associated Conditions
Bacterial Infections, Obstructive Hypertrophic Cardiomyopathy, Skin Irritation, Bacterial skin infections, Ethylene glycol overdose, Fat occlusion in central venous catheter, Methanol overdose
Associated Therapies
Hand Hygiene, Skin disinfection
Clinical Trials
Related News

Measuring the Neuroimmune Response to Alcohol

Early Phase 1
Completed
Conditions
Alcohol Drinking
Interventions
First Posted Date
2020-01-31
Last Posted Date
2023-11-07
Lead Sponsor
Yale University
Target Recruit Count
14
Registration Number
NCT04251221
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Cannabis Impairment Detection Application (CIDA)

Not Applicable
Completed
Conditions
Alcohol Intoxication
Driving Under the Influence
Marijuana Intoxication
Interventions
First Posted Date
2020-01-18
Last Posted Date
2021-07-12
Lead Sponsor
Advanced Brain Monitoring, Inc.
Target Recruit Count
124
Registration Number
NCT04230460
Locations
🇺🇸

University of Iowa. National Advanced Driving Simulator, Iowa City, Iowa, United States

Steroid Profile: Differentiating Testosterone Administration From (Simultaneous) Ethanol Consumption

First Posted Date
2019-11-18
Last Posted Date
2019-11-18
Lead Sponsor
Parc de Salut Mar
Target Recruit Count
4
Registration Number
NCT04166786
Locations
🇪🇸

IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain

Imaging Glutamate Release From Alcohol

Early Phase 1
Completed
Conditions
Alcohol Drinking
Interventions
First Posted Date
2019-11-12
Last Posted Date
2024-10-09
Lead Sponsor
Yale University
Target Recruit Count
8
Registration Number
NCT04159688
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells

Phase 1
Recruiting
Conditions
BRCA1 Mutation
Pancreatic Acinar Cell Carcinoma
Breast Cancer Metastatic
BRCA2 Mutation
Pancreatic Cancer
Metastatic Pancreatic Ductal Adenocarcinoma
Breast Cancer Stage IV
Adenocarcinoma of the Breast
Pancreatic Ductal Adenocarcinoma
Metastatic Pancreatic Cancer
Interventions
Drug: Vitamin B12B
Device: Autologous Hematopoietic Stem Cells
First Posted Date
2019-11-04
Last Posted Date
2024-06-26
Lead Sponsor
General Oncology, Inc.
Target Recruit Count
10
Registration Number
NCT04150042
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Acute Effects of Alcohol Use on Chronic Orofacial Pain

Not Applicable
Completed
Conditions
Temporomandibular Joint Disorders
Interventions
Other: Placebo
First Posted Date
2019-07-15
Last Posted Date
2023-07-27
Lead Sponsor
University of Florida
Target Recruit Count
48
Registration Number
NCT04019093
Locations
🇺🇸

Center for Pain Research and Behavioral Health at UF Health, Gainesville, Florida, United States

A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: ASP8062 Placebo
First Posted Date
2019-07-01
Last Posted Date
2024-11-05
Lead Sponsor
Astellas Pharma Global Development, Inc.
Target Recruit Count
20
Registration Number
NCT04003402
Locations
🇺🇸

Parexel International - EPCU Baltimore, Baltimore, Maryland, United States

Behavior Brain Responses

Early Phase 1
Completed
Conditions
Alcohol Drinking
Central Nervous System Depression
Drinking Behavior
Physiological Effects of Drugs
Interventions
Other: Placebo
First Posted Date
2019-05-28
Last Posted Date
2025-01-31
Lead Sponsor
University of Chicago
Target Recruit Count
30
Registration Number
NCT03964350
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Alcohol, Behavior, and Brain Imaging

Early Phase 1
Completed
Conditions
Alcohol Drinking
Binge Drinking
Drinking Behavior
Substance-Related Disorders
Ethanol
Physiological Effects of Drugs
Central Nervous System Depressants
Interventions
Other: Placebo
First Posted Date
2019-04-29
Last Posted Date
2022-04-25
Lead Sponsor
University of Chicago
Target Recruit Count
80
Registration Number
NCT03930446

Sex Differences in the Response to Abstinence From Alcohol.

Phase 1
Recruiting
Conditions
Alcohol Use Disorder
Interventions
Behavioral: Abstinence from alcohol
Behavioral: Usual drinking
First Posted Date
2019-02-01
Last Posted Date
2024-08-22
Lead Sponsor
Indiana University
Target Recruit Count
160
Registration Number
NCT03827460
Locations
🇺🇸

University Hospital, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy